Peripheral Vascular Devices Market

Market Definition

Peripheral vascular devices are used for treating peripheral arterial or coronary arterial disease and also used for peripheral endovascular and coronary procedure. The peripheral vascular devices include Carotid and Renal Artery Stents, Peripheral Vascular Stents, Peripheral Embolic Protection Devices, Arteriotomy Closure Devices, PTA Balloon Catheters, Renal Denervation Catheters, Peripheral Guidewires, and PV Embolization Plugs & Coils.

Global Peripheral Vascular Devices market size is valued at USD 9.4 billion in 2025 and projected to grow at a CAGR of 6.6% during the forecast period, reaching USD 15.7 billion by 2033

Market Dynamics

Rising incidence of peripheral arterial disease (PAD) is boosting the market growth. According to the National Center for Chronic Disease Prevention, globally, more than 236·62 million people aged 25 years and older live with peripheral artery disease in 2019. According to the American Heart Association, in 2018, approximately 8.5 million people age 40 and older have peripheral artery disease (PAD) in the U.S. In Canada, 800,000 people suffer from some form of peripheral artery disease (PAD). Further, increasing regulatory approval of peripheral vascular devices is a key driving factor of the market. For instance, Concept Medical has received CE Certification for Magic Touch PTA 0.035 OTW (Percutaneous Transluminal Angioplasty), a Sirolimus drug-coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease. MagicTouch PTA prevents re-narrowing of superficial femoral and popliteal arteries in patients with peripheral artery disease. However, product recall of peripheral vascular devices might hamper the market growth. For instance, Medtronic has recalled its 6-French Sherpa NX Active Guide catheter because the outer material may separate from the device, which results in the detachment of fragments and exposure of stainless-steel braid wires. The US Food and Drug Administration (FDA) has identified Sherpa NX Active Guide catheter as a class 1 recall, the most serious kind, because of the potential for serious injuries or death. Moreover, technological innovations in peripheral vascular devices would provide lucrative opportunities for the market in coming years.

Market Segmentation

The global peripheral vascular devices market is mainly classified based on type and end user. Type is further segmented into Carotid and Renal Artery Stents, Peripheral Embolic Protection Devices, Arteriotomy Closure Devices, PTA Balloon Catheters, Peripheral Vascular Stents, Peripheral Guidewires, Renal Denervation Catheters, and PV Embolization Plugs & Coils. By end user the market is divided into Hospitals, Clinics, Ambulatory Surgical Centers, and Others. 

Peripheral Vascular Stents segment is valued at USD 2.1 billion in 2026 and is projected to reach USD 2.7 billion by 2033, at a CAGR of 3.6% during the forecast period. Due to the commercialization of peripheral vascular stents, increasing investigational studies related to peripheral vascular stents, R&D activities, partnership between companies to expand the peripheral vascular stents market at the global scale and increasing regulatory approval of peripheral vascular stents. For instance, Boston Scientific has received U.S. Food and Drug Administration (FDA) approval to market the Eluvia Drug-Eluting Vascular Stent System, developed for the treatment of peripheral artery disease (PAD). The Eluvia stent utilizes a drug-polymer combination to offer sustained release of the drug paclitaxel, designed to prevent tissue regrowth, which might otherwise block the stented artery.

By End User, Hospitals segment is projected to reach USD 10 billion by 2033, at a CAGR of 5.8% during the forecast period. 

Regional Analysis

Based on geography, the global peripheral vascular devices market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the global peripheral vascular devices market in 2020, due to the rising prevalence of peripheral arterial disease (PAD), government funding for research and development activities and technologically advanced of peripheral vascular devices, and commercialization of regulatory approved peripheral vascular devices. For instance, Terumo Medical Corporation (TMC) has introduced the R2P MISAGO RX Self-expanding Peripheral Stent. The introduction of R2P MISAGO helps physicians to provide the benefits associated with a radial access approach to patients with peripheral artery disease (PAD). R2P MISAGO is the longest stent platform designed for above-the-knee PAD interventions via radial access, incorporating Rapid Exchange (RX) technology and innovative bare metal stent design.

Competitive landscape

Key players operating in the peripheral vascular devices industry include Abbot Laboratories, Medtronic, Boston Scientific Corporation, Terumo Corporation, Becton, Dickinson and Company, Teleflex Incorporated, Cordis, Cook Medical, Koninklijke Philips N.V., and Merit Medical.

The increasing investment by the companies on R&D activities on peripheral vascular devices, commercialization of new peripheral vascular devices, the collaboration between companies to expand the peripheral vascular devices business, and increasing regulatory approval of peripheral vascular devices are some of the strategies adopted by the major companies. For instance, on November 2, 2020, Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for Ranger Drug-Coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA). The approval is based on results from the RANGER II SFA pivotal trial, which helped to evaluate the safety and effectiveness of the Ranger DCB versus standard percutaneous transluminal angioplasty (PTA) for the treatment of patients with PAD in the SFA and PPA. 

Peripheral Vascular Devices Market Key Segments:

By Type

• Carotid and Renal Artery Stents
• Peripheral Embolic Protection Devices
• Arteriotomy Closure Devices
• PTA Balloon Catheters
• Peripheral Vascular Stents
• Peripheral Guidewires
• Renal Denervation Catheters
• PV Embolization Plugs & Coils

By End User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Key Global Peripheral Vascular Devices Industry Players

• Abbot Laboratories
• Medtronic
• Boston Scientific Corporation
• Terumo Corporation
• Becton, Dickinson and Company
• Teleflex Incorporated
• Cordis
• Cook Medical
• Koninklijke Philips N.V.
• Merit Medical

Report Attributes	Details
Study Period	2021-2033
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2033
Historical Period	2021-2025
Growth Rate	CAGR 6.6% from 2026 to 2033
Revenue Unit	USD billion
Sales Volume Unit	Thousand Units
Segmentation	By Type, End User, and Region
By Region	North America (By Type, End User, and Country) United States Canada Mexico
	Europe (By Type, End User, and Country) Germany France UK Italy Spain Russia Rest of the Europe
	Asia Pacific (By Type, End User, and Country) China Japan India South Korea Australia Southeast Asia Rest of Asia Pacific
	South America (By Type, End User, and Country) Brazil Argentina Rest of South America
	Middle East and Africa (By Type, End User, and Country) Saudi Arabia UAE South Africa Rest of Middle East and Africa

What Report Provides

• Full in-depth analysis of the parent Industry
• Important changes in market and its dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional growth potential